Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy.
about
Overexpression of phosphoserine aminotransferase PSAT1 stimulates cell growth and increases chemoresistance of colon cancer cellsGenotoxic anti-cancer agents and their relationship to DNA damage, mitosis, and checkpoint adaptation in proliferating cancer cellsNon-Canonical Cell Death Induced by p53ECA39 is a novel distant metastasis-related biomarker in colorectal cancerCelecoxib attenuates 5-fluorouracil-induced apoptosis in HCT-15 and HT-29 human colon cancer cells.Aloe vera induced biomimetic assemblage of nucleobase into nanosized particlesTranscriptional activation and cell cycle block are the keys for 5-fluorouracil induced up-regulation of human thymidylate synthase expression.Resveratrol abrogates the temozolomide-induced G2 arrest leading to mitotic catastrophe and reinforces the temozolomide-induced senescence in glioma cells.Targeting the DNA replication checkpoint by pharmacologic inhibition of Chk1 kinase: a strategy to sensitize APC mutant colon cancer cells to 5-fluorouracil chemotherapyLack of p53 function promotes radiation-induced mitotic catastrophe in mouse embryonic fibroblast cells.Activation of meiosis-specific genes is associated with depolyploidization of human tumor cells following radiation-induced mitotic catastrophe.Elevated platelet count as predictor of recurrence in rectal cancer patients undergoing preoperative chemoradiotherapy followed by surgery.Enhancement of 5-fluorouracil-induced in vitro and in vivo radiosensitization with MEK inhibition.Biological evaluation of 5-fluorouracil nanoparticles for cancer chemotherapy and its dependence on the carrier, PLGACurcumin mediates chemosensitization to 5-fluorouracil through miRNA-induced suppression of epithelial-to-mesenchymal transition in chemoresistant colorectal cancer.Multicentre phase II study of leucovorin plus pharmacokinetic modulating chemotherapy for metastatic colorectal cancer.Clinical significance of radiation-induced CD133 expression in residual rectal cancer cells after chemoradiotherapyMethacrylic-based nanogels for the pH-sensitive delivery of 5-fluorouracil in the colonSchedule-dependent activity of 5-fluorouracil and irinotecan combination in the treatment of human colorectal cancer: in vitro evidence and a phase I dose-escalating clinical trial.Clinical significance of enlarged lateral pelvic lymph nodes before and after preoperative chemoradiotherapy for rectal cancerEpigallocatechin-3-gallate targets cancer stem-like cells and enhances 5-fluorouracil chemosensitivity in colorectal cancer.Mimicking Metastases Including Tumor Stroma: A New Technique to Generate a Three-Dimensional Colorectal Cancer Model Based on a Biological Decellularized Intestinal ScaffoldMirk regulates the exit of colon cancer cells from quiescence.Lack of M30 expression correlates with factors reflecting tumor progression in rectal cancer with preoperative chemoradiotherapyAdvances and directions in chemotherapy using implantable port systems for colorectal cancer: a historical review.Identification of candidate anti-cancer molecular mechanisms of Compound Kushen Injection using functional genomics.Tip110 Regulates the Cross Talk between p53 and Hypoxia-Inducible Factor 1α under Hypoxia and Promotes Survival of Cancer Cells.Improved cytotoxic effects of Salmonella-producing cytosine deaminase in tumour cells.High glucose modulates antiproliferative effect and cytotoxicity of 5-fluorouracil in human colon cancer cells.Concurrent chemotherapy inhibits herpes simplex virus-1 replication and oncolysis.Cyclin E and histone H3 levels are regulated by 5-fluorouracil in a DNA mismatch repair-dependent manner.Anti-hepatocarcinoma effects of 5-fluorouracil encapsulated by galactosylceramide liposomes in vivo and in vitro.Alteration of Drug Sensitivity in Human Colon Cancer Cells after Exposure to Heat: Implications for Liver Metastasis Therapy using RFA and Chemotherapy.RhoGDI2 confers resistance to 5-fluorouracil in human gastric cancer cells.Toxicities and therapeutic effect of 5-fluorouracil controlled release implant on tumor-bearing rats.Less cytotoxicity to combination therapy of 5-fluorouracil and cisplatin than 5-fluorouracil alone in human colon cancer cell lines.Overexpression of lamin B1 induces mitotic catastrophe in colon cancer LoVo cells and is associated with worse clinical outcomes.Steviol, a natural product inhibits proliferation of the gastrointestinal cancer cells intensively.
P2860
Q24646343-3E92CCAD-7F83-450D-92A5-E7095B3388CCQ26851196-44E47F1C-5A09-435C-B342-F29C95DE1583Q28080158-DC49C4D2-F154-47A6-A932-64E8F2723F0CQ33909844-CD12E8D4-85B1-441A-A7A2-E169A12344DAQ34099447-7A143B42-8523-4900-93CC-22D98D760821Q34189323-A835F38B-CE09-409C-BA7B-6AEDCEC98D67Q34443004-A5DC2C74-F89F-4F96-90EA-A8FDE5A67A28Q34632817-F43031B4-88C8-4E09-AEF5-B899A60580FFQ34654741-69ADEB55-11ED-446B-B92C-575B03555989Q34682107-33B52882-FDF4-4B6A-857A-5A2C3E94A9C8Q34956023-82D452EB-8D36-4AAE-A077-DB44B7F9BEBCQ35110652-A44D7178-730A-49D6-B92F-D7745BC8B6B4Q35146186-FA995FF9-75FE-4C60-9BBA-F3EB908F2442Q35254387-00F55836-71C4-486D-8888-7A1AE8251344Q35452772-4AA22927-CCE1-45D9-8E4F-4CE23D939D41Q36216117-06F8534B-23B9-430C-A16D-FA9D2CC90D47Q36224182-80445D69-B5F1-4B80-8433-937AE4DE7D97Q36410956-EC8A5F67-E4C1-46B5-AA78-D1AB0C99432AQ36610474-E93474F6-05CF-4072-96DE-F34A06EF3EF4Q36954080-85875B81-DEF7-4C54-BAC2-4A6980FE7B0AQ37085982-56999D68-D6CA-40F0-9ADF-09D60D550817Q37091367-28C2DB10-7FC1-4AE8-8D1C-31964D908B03Q37371684-362EB6A6-19C3-4EB7-A319-27C471916CDCQ37562470-010D0C66-0A92-47F7-8130-131627539C7AQ38124755-4559EC26-3AFB-4A39-8D5D-21081C8AC183Q38747762-722C575F-9C8D-424D-AF42-A975E1332315Q38879306-0B2B8800-869A-400B-8EA4-D99D92B7CA44Q38955988-9A472AA7-77EF-4B11-AF4B-89927E78D45EQ39053456-8DA0A384-C8AB-4F91-8ADF-99AB7C755A33Q39205115-48C7C58F-DC60-48D6-BA66-EB30B1FE4341Q39588997-A5185FD7-655C-4488-95C5-7149ED79DDD0Q40431168-5C2333F9-FEC4-4755-B191-E4836BD21E46Q41180643-ED2C02FE-CE6F-4752-81BF-11B6125493C4Q42100478-7958610A-7B27-4796-86CE-2F8E11C9EC14Q42181711-EAC1831F-5B9B-46B7-8460-F4ADE3A71A3EQ43159614-7F48276F-418B-401A-9874-600B48FBF618Q47426514-349C8253-9F52-4AAC-A119-3337D418176CQ55077362-723387C3-0ABA-4079-A433-7DDF1A97880B
P2860
Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Dual antitumor effects of 5-fl ...... netic modulating chemotherapy.
@ast
Dual antitumor effects of 5-fl ...... netic modulating chemotherapy.
@en
type
label
Dual antitumor effects of 5-fl ...... netic modulating chemotherapy.
@ast
Dual antitumor effects of 5-fl ...... netic modulating chemotherapy.
@en
prefLabel
Dual antitumor effects of 5-fl ...... netic modulating chemotherapy.
@ast
Dual antitumor effects of 5-fl ...... netic modulating chemotherapy.
@en
P2093
P1433
P1476
Dual antitumor effects of 5-fl ...... inetic modulating chemotherapy
@en
P2093
Furuyama JI
Hashimoto-Tamaoki T
Kusunoki M
Yamamura T
Yoshikawa R
P304
P407
P577
2001-02-01T00:00:00Z